Non-small cell lung cancer: Which Medications Are Safest? (519 Drugs Compared)
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
519 medications are used for Non-small cell lung cancer, with 57,678 combined adverse event reports. The most reported drugs for Non-small cell lung cancer are NIVOLUMAB and CARBOPLATIN.
57,678
Total Reports
519
Drugs Used
All Medications for Non-small cell lung cancer Ranked by Safety Reports
| Drug | Brand | Reports | Deaths (all) | Hosp. (all) | Death Rate |
|---|---|---|---|---|---|
| NIVOLUMAB | OPDIVO | 9,987 | 23,086 | 36,530 | 26.3% |
| CARBOPLATIN | Carboplatin | 7,939 | 12,544 | 35,869 | 14.9% |
| PEMBROLIZUMAB | KEYTRUDA | 6,893 | 15,543 | 35,472 | 18.6% |
| OSIMERTINIB | TAGRISSO | 6,358 | 12,456 | 5,277 | 44.9% |
| PEMETREXED | Pemetrexed | 5,179 | 3,876 | 10,697 | 16.5% |
| PACLITAXEL | PACLITAXEL PACLITAXEL | 4,609 | 12,030 | 31,638 | 15.6% |
| ATEZOLIZUMAB | Tecentriq Hybreza | 4,459 | 8,520 | 15,094 | 25.3% |
| BEVACIZUMAB | JOBEVNE | 4,136 | 17,498 | 23,114 | 22.4% |
| DURVALUMAB | IMFINZI | 3,396 | 5,088 | 5,968 | 29.7% |
| ERLOTINIB | Erlotinib | 3,359 | 6,791 | 3,693 | 30.2% |
| IPILIMUMAB | YERVOY | 2,987 | 8,043 | 17,031 | 22.0% |
| AFATINIB | Gilotrif | 2,010 | 1,346 | 2,055 | 22.1% |
| ALECTINIB | ALECENSA | 1,946 | 1,055 | 1,553 | 11.5% |
| GEFITINIB | Gefitinib | 1,786 | 1,047 | 853 | 22.3% |
| CISPLATIN | CISplatin | 1,762 | 8,387 | 17,469 | 17.7% |
| CRIZOTINIB | Xalkori | 1,724 | 3,173 | 2,520 | 31.9% |
| DOCETAXEL | Docetaxel | 1,294 | 6,068 | 13,463 | 9.3% |
| BRIGATINIB | Alunbrig | 1,130 | 729 | 912 | 22.2% |
| CERITINIB | ZYKADIA | 1,019 | 786 | 804 | 28.1% |
| LORLATINIB | Lorbrena | 968 | 1,542 | 1,232 | 28.0% |